2011). However, this architecture also makes axons highly susceptible to damage, being axonal 66 degeneration a common and early feature of many neurological disorders, including ALS, PD 67 and AD, as well as after traumatic or chemical insults (Coleman, 2005; Benarroch, 2015; Gerdts 68 et al., 2016) . 69
The degenerative process of mechanically isolated axons, known as Wallerian degeneration 70 (Waller, 1850) , has been broadly used as a model to unveil the cellular and molecular 71 mechanisms of axonal degeneration (Coleman and Freeman, 2010; Conforti et al., 2014) . 72
Likewise, chemotherapeutic agents have also been used to model chemotherapy-induced 73 peripheral neuropathies, a serious yet common side effect of cancer treatment (Taillibert et al., 74 2016) . Mechanistic studies in transgenic models displaying delayed Wallerian degeneration 75 axonal self-destruction program (Court and Coleman, 2012; Wang et al., 2012a) . The expression 77 of the Wld s protein is the most studied model of delayed axonal degeneration (Mack et al., 2001 ; 78 Adalbert et al., 2005; Hoopfer et al., 2006) . Loss-of-function studies have also identified mutants 79 that exhibit Wld s -like protection of severed axons, as dSarm/Sarm1 (Osterloh et al., 2012; 80 Essuman et al., 2017) and Axundead (Neukomm et al., 2017) , sustaining that Wallerian 81 degeneration is indeed an active and regulated process. Necroptosis is characterized by cellular and organelle swelling, plasma membrane rupture and 92 cellular contents release, inducing a pro-inflammatory response (Vandenabeele et al., 2010; 93 Orozco and Oberst, 2017). Upon TNFα receptor activation, both apoptosis or necroptosis can be 94 triggered (Degterev et al., 2005) . Normally, TNFα induces apoptosis through caspase-8 95 activation, which in turn inhibits necroptosis by RIPK1 and RIPK3 cleavage (Sun and Wang, 96 2014) . Under caspase-8 inhibition, both kinases are phosphorylated, triggering phosphorylation 97 and oligomerization of MLKL and membrane permeabilization (Cai et al., 2013; Tummers and 98 Green, 2017). Other necroptotic activators have been recently described, including increased 99 intracellular Ca 2+ ( Nomura et al., 2014; Wallach et al., 2016) both, neuronal autonomous roles for necroptosis, as well as non-cell autonomous mechanisms 106 participating in nervous system dysfunction (Tonnus and Linkermann, 2017) , but whether 107 necroptosis is activated in a specific neuronal compartment, such as the axon, has not been 108 defined. 109
Here, we demonstrate that pharmacological inhibition and genetic knock-down of central 110 necroptotic players strongly delayed morphological and functional loss of axons in both, PNS 111 and CNS models of Wallerian degeneration. Furthermore, we observed that after injury 112 necroptosis is activated early in axons, followed by mitochondrial fragmentation and progressive 113 degeneration of axons. Inhibition of mitochondrial fission delayed axonal degeneration, 114 sustaining that mitochondrial fragmentation is a crucial axon degeneration effector after 115 necroptosis activation. Taken together, our results identify necroptosis as the programmed 116 mechanism for axonal degeneration, revealing novel molecular targets for neuroprotective 117 therapies in which axonal degeneration is a common factor. 118 119 Methods medium and immersed in a 1.5 ml tube with 4% paraformaldehyde in 1X PBS for 1h at RT. 145 Then, nerves were washed 3 times for 10 min in 1X PBS and transferred into a 35mm culture 146 dish with 1X PBS to remove the perineurum. The bundles were separated with acupuncture 147 needles and placed in a drop of 1X PBS over a Tespa-coated slide, and the fibers were teased and 148 attached to the slide. Once the drop was dried out, the slides were immersed in cold 100% 149 acetone for 20 min at -20°C to proceed with the immunofluorescence protocol detailed below. 150
Dorsal root ganglion cultures 151
Briefly, E16 rat embryos were decapitated, and the limbs and organs were removed. The spinal 152 cord with dorsal root ganglia (DRGs) was dissected and placed in a Petri dish containing cold L-153 15 medium (Gibco, 11415-064). For DRG explants, complete DRGs were cultured in 24-well 154 dishes containing 400 μl of Neurobasal medium, 2% B27, 0.3% L-glutamine, 1% 155 streptomycin/penicillin, 4 μM aphidicolin (Sigma, A0781), 7.5 μg/ml 5-fluoro-2-deoxyuridine 156 (Sigma, F0503), and 50 ng/ml nerve growth factor (NGF) (Invitrogen, 13257-019). The mixture 157 of aphidicolin and fluoro-2-deoxyuridine inhibits proliferation of Schwann cells by inhibition of 158 DNA polymerase (Spadari et al., 1985; Wallace and Johnson, 1989) , thus constituting a highly 159 pure sensory neuron culture (Heermann et al., 2012) . DRGs were cultured for 7-11 days at 37°C 160 and 5% CO 2 . Axotomy of DRG explants was made using a micropipette tip to separate all the 161 axons from the somas. Chemical injury was achieved by adding 1 µM vinblastine (Sigma, 162 V1377) to the culture medium. 163
Western Blot 164
Axons obtained by axotomy from rat DRG explants (n=3) were homogenized in RIPA buffer 165 with 1% protease inhibitor cocktail (Sigma, P8340) plus PMSF and phosphatase inhibitors 166 NaVO 3 and NaF. Proteins were quantified by BCA assay (Thermo Fisher Scientific, 23225) and 167 40 µg of lysate were combined with loading buffer, subjected to 10% SDS-PAGE 168 electrophoresis, and transferred to polyvinylidene fluoride membranes (Thermo Fisher Scientific 169 88518). The following primary antibodies were used at 1:1000 dilution: anti-RIPK3 (Abcam 170 Cat# ab16090, RRID:AB_302252), anti p-MLKL (Abcam Cat# ab196436, RRID:AB_2687465) 171 and anti-MLKL (Abcam, Cat# ab172868, RRID:AB_2737025). Secondary antibodies used were 172 goat anti-mouse HRP (Bio-Rad / AbD Serotec Cat# 170-6516, RRID:AB_11125547) and goat 173 anti-rabbit HRP (Bio-Rad / AbD Serotec Cat# 170-6515, RRID:AB_11125142) at 1:3000. 174
Western blots were revealed by enhanced chemiluminescence in a Chemi-doc Gel Imaging 175 System (Bio-Rad, XRS+). Band analysis was performed using Image Lab Software (Image Lab 176 Software, RRID:SCR_014210) and ImageJ software (ImageJ, RRID:SCR_003070). 177
Quantitative Real-Time PCR 178
The mRNA levels of RIPK3 and MLKL were analyzed in DRG neurons infected with lentivirus 179 containing shRIPK3 or shMLKL before and after axotomy. Neurons were homogenized in Trizol 180 reagent (Invitrogen, Carlsbad, CA, USA) for extraction of total RNA based on the 181 Immunofluorescence 199
For immunofluorescence analysis, the nerves explants were fixed by immersion in 4% 200 paraformaldehyde in 1X PBS for 1 h, followed by three 10 min washes in 1x PBS, sucrose 201 gradient (5%, 10%, 20% in 1x PBS), and then embedded in OCT (Sakura Tissue Tek, 4583). 202
Cryostat sections from the middle of the explants were cut transversely at 10 μm thickness and 203 mounted on Superfrost Plus slides (Thermo Fisher Scientific, J1800AMNZ). Sections were 204 washed in 1X PBS for 10 min and then blocked/permeabilized in 0.1% Triton X-100, 5% fish 205 skin gelatin (Sigma, G7765) in 1X PBS for 1h at RT. Sections were incubated in primary 206 antibodies in 0.1% Triton X-100, 1% fish skin gelatin solution overnight at 4°C, washed in 1X 207 PBS 3 × 10 min, and incubated in secondary antibodies for 2h at RT. Sections were washed 3 × 208 10 min in 1X PBS and mounted in Fluoromount G (EMS, 17984-25). For IF analysis of 209 embrionary DRG explants, they were fixed in 4% paraformaldehyde in 1X PBS for 20 min, 210 followed by three 10 min washes in 1X PBS. The following antibodies were used for 211 immunofluorescence analysis: rabbit anti-neurofilament heavy chain (NFH) (Sigma, N4142) at 212 1:5000; chicken anti-neurofilament medium chain (Millipore Cat# AB5735, RRID:AB_240806) 213 at 1:2000; anti-acetylated tubulin (Sigma-Aldrich Cat# T6793, RRID:AB_477585) at 1:1000 and 214 COXIV (Abcam Cat# ab16056, RRID:AB_443304) at 1:1000. We used secondary antibodies 215 conjugated to Alexa Fluor dyes at 1:1000 (Jackson ImmunoResearch Laboratories). 216
Electron microscopy 217
Nerves were fixed overnight by immersion in 2.5% glutaraldehyde, 0.01% picric acid and 0.1 M 218 cacodylate buffer, pH 7.4. Nerves were rinsed in the same buffer, immersed in 1% OsO4 for 1 h 219 followed by in block incubation with 2% uranyl acetate for 2 h. Nerves were dehydrated with a 220 graded series of ethanol, propylene oxide and infiltrated with Epon (Ted Pella Inc, USA). 221
Ultrathin sections from the middle of the explants were contrasted with 1% uranyl acetate and 222 lead citrate. Grids were examined with a Philips Tecnai 12 electron microscope operated at 80 223 kV. Negative films were developed and scanned. 224
Axonal degeneration quantification 225
Number of axons per area of nerve tissue was assessed in confocal images of neurofilament-226 immunostained explant sections (matched for laser power, photomultiplier tube gain/offset, and 227 post processing) using the particle analysis macro of ImageJ. Relative neurite integrity was based 228 on the ratio of the areas of fragmented axons versus total axonal area (Villegas et al., 2014) . 229
Degenerated axon fragments were detected using the particle analyzer algorithm of ImageJ 230 (NIH, USA) and the total fragmented axon area versus total axonal area was used to estimate a 231 degeneration index. 232
Electrophysiology 233
The viability of sciatic nerve explants was tested by the recording of the compound action 234 potential (CAP). Mice sciatic nerve explants were desheated from the perineurum and transferred 235 to a recording chamber filled with Hank's balanced solution, supplemented with 5 mM HEPES 236 buffer, pH 7.35 (Alcayaga et al., 1998) . The proximal end of each explant was pinned onto a 237 stimulating bipolar tungsten electrode at the bottom of the recording chamber, while the distal 238 end was pinned onto the recording electrode at the top of the chamber surrounded by mineral 239 oil. Stimulating pulses of 50 Psec duration were delivered at 1 sec intervals. The maximum fast 240 monophasic A wave was obtained by increasing the intensity of the pulse. The maximal peak 241 height and area of the CAP was analyzed. 242
Virion production and lentiviral transduction 243
Human embryonic kidney 293T cells (ATCC) were transfected into 15 cm2 dishes using the 244 calcium chloride (1.25 M) method. Media was replaced 4 hours after the initial transfection, and 245 48 hours later lentivirus enriched media were collected and cleared by slow speed centrifugation 246 at 1,500 rpm for 5 minutes. Subsequently, the conditioned media was filtered through a 0.45-μm 247 pore conic tube filter. The lentiviruses were concentrated using the Lenti-X-concentratorTM 248 reagent (Clontech: Mountainview, CA, USA) and then stored at -80°C. Four plasmids for 249 lentiviral transduction of RIPK3 shRNA were designed by Biosettia using the Rattus norvegicus 250 RIPK3 mRNA sequence (NCBI reference sequence NM_139342.1) and cloned in a pLVRNAi 251 vector that co-express GFP as reporter gene. The ripk3 shRNA oligo vector used sequences are: 252 GAAAGGCTTCTAAAGCAA; GAAGCATCATTTGGGCAT; GAAGAAACAGCAATCCTT 253 ;CCTACAGTCTATTGTCTT. One plasmid for lentiviral transduction of MLKL shRNA, were 254 designed and packaged by Vigene Bioscience using the Rattus norvegicus MLKL mRNA 255 sequence (NCBI reference sequence XM_008772571.2) and cloned in a pLV-RNAi vector that 256 co-express GFP as reporter gene. The mlkl shRNA oligo vector used sequences are: 257 12 lentiviral transduction of scramble shRNA, were designed by Vigene Bioscience and cloned in a 259 pLV-RNAi vector that co-express GFP as reporter gene. Transduction of DRG explants was 260 performed in 300 Pl of free-serum media with 1 x 10 6 TU per explant in 24-well plates at DIV 2 261 and maintained in culture until axotomy or vinblastine treatment at DIV7. 262
Statistical Analysis 263
Statistical significance was stablished at p<0.05 by One-way ANOVA with Tukey post-test or 264 Two-way ANOVA for multiple comparisons. The analysis was performed using the GraphPad 265
Prism Software v6.0 and carried out with data obtained from at least three independent 266 experiments. 267
268

Results
269
RIPK1 inhibition delays axonal degeneration in both the PNS and CNS. 270
To explore whether necroptosis is associated to axonal degeneration, we first used an ex vivo 271 sciatic nerve model of injury-induced axonal degeneration, which allows to study axonal 272 degeneration in the absence of any effects from the neuronal cell body or the immune system 273 (Barrientos et al., 2011). We tested the effect of necrostatin-1 (Nec-1), a drug that inhibits the 274 kinase activity of RIPK1 and prevents RIPK1/RIPK3 complex formation, strongly inhibiting cell 275 death by necroptosis (Degterev et al., 2008) . In vehicle-treated explants, more than 50% of axons 276 have degenerated by 48 hours (0h Ctrl: 5.612r0.29 vs 48h veh: 1.625r0.26 axons/100 Pm 2 , 277 F(10, 22) = 94.65, p 0.0001, ANOVA), as observed by NFH immunostaining and quantitative 278 analysis of axonal density ( Figure 1A, B ). In explants treated with Nec-1 (100 µM), a significant 279 protection from axonal degeneration was observed at 48 hours (48h veh: 1.625r0.26 vs 48h Nec-280 1: 2.948r0.28 axons/100 Pm 2 , F(10, 22) = 94.65, p = 0.0094, ANOVA) ( Figure 1A, B ). To determine the protective effect of Nec-1 in damaged CNS axons, we analyzed optic nerve 282 explants using the same approach described above. Vehicle-treated optic nerve explants showed 283 a dramatic reduction in axonal density after 4 days in culture (0h Ctrl: 18.84r0.80 vs 4d veh: (Figure 2A ). In Nec-1 treated nerves, a significant inhibition of the injury induced A-307 wave amplitude decay was observed compared to damaged and vehicle treated nerves (24h veh: 308 223.3r4.74 vs 24h Nec-1: 309.6r5.69 mV, F(2, 6) = 557.4, p 0.0001, ANOVA) ( Figure 2A and 309 B). We also evaluated the recruitment of excitable fibers within the nerve at a fixed stimulus 310 intensity. Myelinated A-fibers of freshly dissected sciatic nerves reached their maximum 311 response at low stimulus intensities. In contrast, nerve explants cultured for 24 hours showed a 312 smaller maximum response, which was only detected under high stimulus intensities, reflecting a 313 lower number of functional axons due to the degenerative process. On the other hand, nerves 314 cultured for 24 hours with Nec-1 showed a significantly higher response than vehicle conditions, 315 which was also reached at lower stimulus intensities ( Figure 2C ). Altogether, these results 316 demonstrate that RIPK1 inhibition can not only protect axons from morphological degeneration 317 after transection but also partially preserve their functional deterioration after nerve damaged. Figure 3A, B) . We measured mitochondrial length in axons from teased fibers of sciatic nerves 329 at 0, 24 and 48h after injury by using confocal microscopy. In intact axons, mitochondria 330 displayed a wide range of lengths from <2 µm up to >8 µm long. At 24 and 48h post-injury the 331 distribution of mitochondrial lengths becomes much narrower and shifted to smaller values 332 ( Figure 3C) , with significant decreases in the mean mitochondrial length (0h Ctrl: 4.116r0.178 333 vs 24h veh: 1.737r0.123 or 48h veh: 0.8024r0.064 Pm, F(2, 6) = 171.9, p 0.0001, ANOVA) 334 ( Figure 3D ). Furthermore, a significant increase in mitochondrial density at 24 and 48h post-335 injury (0h Ctrl: 22.05r1.392 vs 24h veh: 34.64r1.734 or 48h veh: 36.21r1.007 mitochondria/100 336 Pm 2 , F(2, 51) = 30.33, p 0.0001, ANOVA) ( Figure 3E ) suggests that the changes in 337 mitochondrial length after axonal damage are associated to a fragmentation process. By electron 338 microscopy of longitudinal sections of sciatic nerves, evidences for mitochondrial fragmentation 339 and swelling were commonly observed at 24 and 48h post injury, respectively ( Figure 3F ). 340
We next tested whether axonal mitochondrial fragmentation after nerve injury was associated to 341 p=0.0006, ANOVA) ( Fig 6A) . In order to determine whether necroptosis is activated during 410 axonal degeneration, DRG explants were damaged by axotomy and the axonal levels of p-MLKL 411 were measured. A significant and transient increase of pMLKL was observed 3h post-axotomy 412 (Ctrl: 1.00r0.194 vs 3h veh: 2.390r0.546 p-MLKL fold induction, p=0.0208), an effect that was 413 significantly inhibited by Nec-1s treatment (3h veh: 2.390r0.546 vs 3h Nec-1: 1.044r0.094, F(7, 414 28) = 3.307, p=0.0276, ANOVA) ( Fig 6B) . Since necroptosis regulators are poorly expressed in 415 the nervous system, we evaluate the specificity and sensitivity of the pMLKL antibody by using 416 lentivirus expressing shRNA sequences designed against MLKL in axons 3h after axotomy, a 417 condition that we already showed to increase pMLKL levels ( Fig 6B) . A significant decrease in pMLKL was found in shMLKL transduced and injured axons (shScr axotomy: 2.203r0.105 vs 419 shMLKL axotomy: 1.425r0.240 pMLKL fold induction, F(1, 8) = 9.743, p=0.0297, ANOVA) 420 ( Fig 6C) . These results indicate that necroptosis is induced in embryonic DRG axons after 421 mechanical injury and that necroptotic regulators levels can be specifically detected by western 422 blot. Furthermore, in order to evaluate the magnitude of the knock-down, MLKL and RIPK3 423 mRNA levels were studied by real time PCR in dissociated DRGs transduced with lentiviral 424 vectors containing shMLKL or shRIPK3 sequences. shMLKL produced a 60% decrease in 425 MLKL mRNA levels compared with shScramble (shScr: 1.000r0.00 vs shMLKL: 426 0.3935r0.084, F(2, 9) = 9.056, p=0.0070, ANOVA), while RIPK3 levels showed non-significant 427 changes after MLKL shRNA. shRNA against RIPK3 showed a 36% in RIPK3 mRNA levels 428 (shScr: 1.000r0.00 vs shRIPK3: 0.6393r0.114, F(2, 9) = 4.647, p=0.0411, ANOVA), while 429 MLKL levels were not significantly affected ( Fig 6D) . The progression of degeneration was associated with an early activation of necroptosis in axons, 464 followed by mitochondrial fragmentation, which was also prevented by RIPK1 inhibition, 465
indicating that necroptosis activation is triggered upstream mitochondrial defects after axonal 466 damage. Actually, inhibition of mitochondrial fission delayed axonal degeneration with the same 467 protective magnitude than necroptosis inhibition, suggesting that both events converge in the 468 same cascade for axonal dismiss. 469
Necroptosis is associated to axonal loss and functional impairment 470
Neurons contain at least two molecularly distinct cell-death programs, one for caspase-dependent 471 apoptosis and another for selective axon degeneration which do not required caspases (Finn et Drp1 is essential for synapse formation (Ishihara et al., 2009 ) and neuronal differentiation and 520 migration (Wang et al., 2014b) , processes in which Drp1 inhibition also affects mitochondrial 521 membrane potential (Kim et al., 2015) . These antecedents could explain why axons are not fully 522 protected from degeneration under Drp1 inhibition, and indeed confirm that regulation of 523 mitochondrial fragmentation is a key step in the degenerative process. 524
Mitochondria-associated membranes (MAMs) constitute the contact sites between endoplasmic 525 reticulum and mitochondria during fission (Friedman et al., 2011) and have been proposed to 526 contribute to mitochondrial dysfunction during axonal degeneration (Villegas et al., 2014) . 527
Interestingly, the active necrosome can translocate to MAMs, where necroptosis could be 528 initiated (Chen et al., 2013) . Consistently, the phosphatase PGAM5, a key regulator of Drp1, has 529 been identified as a novel necrosome component (Wang et al., 2012b) . Our results indicate that 530 necroptosis could mediate axonal degeneration by inducing mitochondrial reshaping. In fact, 531 Drp1 and RIPK1 inhibition reached similar magnitudes of axonal protection, suggesting that they 532 belong to the same pathway, in which necroptosis is first activated to then induce mitochondrial 533 fragmentation and axonal degeneration. This observation is sustained by results showing delayed 534 mitochondrial fragmentation under RIPK1 inhibition, strengthening the idea that mitochondrial 535 fission is a convergent point between programmed necrosis and axonal death. According to our 536 results, it has been shown that loss of RIPK3 can rescue Drp1-KO Purkinje neurons from 537 degeneration, modulating mitochondrial morphology from large spheres into elongated tubules 538 (Yamada et al., 2016) . Pharmacological studies with Nec-1 have indicated that RIPK1 inhibition 539 improves mitochondrial function after spinal cord injury , however genetic 540 approaches like those performed in our work should be carried out to directly determine the 541 mechanism involved in necroptosis-mediated degeneration and its connection with mitochondrial 542 reshaping. 543
The role of mitochondrial fragmentation and mPTP formation in necroptosis has been a subject 544 of debate, especially considering that MLKL can directly permeabilize the plasma membrane 545 leading to cellular dismiss. More recent evidence demonstrate that the executory mechanisms of 546 necroptosis can be diverse and are highly dependent on cellular type and context. In sepsis-547 mediated kidney injury, necrosome formation can lead to mitochondrial dysfunction and ROS 548 production by inhibition of mitochondrial complex I and III (Sureshbabu et al., 2018) , and in 549 other cells types necroptosis activation can enhances aerobic respiration and ROS production 550 potential (CAP) was measured in sciatic nerve explants cultured for 24 hours in the presence or 873 absence of Nec-1 (100 µM). CAP A-wave length and amplitude were registered in vehicle-874 treated nerves (A). The maximum peak of the CAP was analyzed (B). The recruitment of 875 excitable fibers within the nerve was measured at fixed stimulus intensity and the maximum fast 876 monophasic A wave was obtained by increasing the intensity of the pulse (C). Nerves cultured 877 for 24 hours with Nec-1 showed a significantly higher response than vehicle conditions. One-878 way ANOVA with post-hoc Tukey, # indicates statistically significant v/s Veh; * indicates 879 significant v/s Ctrl. 880 
